KRM Ayurveda Limited (NSE: KRMAYURVED) is a Delhi-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹521 Cr, it ranks #1,984 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 26 in Pharmaceutical Contract Manufacturing Services. The share price was ₹244.75 as of 16 Nov 2026.
| Current Price | ₹244.75 |
|---|---|
| Market Cap | ₹521 Cr |
| NSE Symbol | KRMAYURVED |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 25.9 |
| Return on Equity | 17.54% |
| Return on Assets | 19.43% |
| Beta (1Y) | 0.97 |
| Headquarters | Delhi |
| Website | www.krmayurvedaindia.com |
| Revenue | ₹32 Cr |
|---|---|
| Net Profit | ₹9 Cr |
| Net Margin | 28.1% |
| EPS (Basic) | ₹4.27 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Promoters held 69.30% of KRM Ayurveda Limited's shares as of Sept 2026, against 69.15% in Mar 2026 (+0.15 percentage points).
KRM Ayurveda Limited operates a network of hospitals and clinics in India as well as abroad through telemedicine consulting and sales. The company provides treatment for kidney disorders, liver cirrhosis, diabetes, fatty liver, and arthritis. It also offers panchakarma therapies, abhyanga (oil massage), shirodhara, herbal steam baths, udvartana (herbal powder massage), chakra healing, orthopedic care, skin and hair care, women’s wellness, geriatric care, stress management, weight management, preventive health plans, and personalized nutrition and yoga consultation. In addition, it provides herbal medicines. The company was incorporated in 2019 and is based in Delhi, India.
1. Healthcare Facilities & Services-This segment operates a network of hospitals and clinics. 2. NA-NA 3. NA-NA 4. NA-NA
1. Healthcare Facilities & Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Infinium Pharmachem Limited | ₹436 Cr | 36.4 | 10.54% | — | +11.7% |
Listed by market capitalisation. Ratios are shown for context only.
KRM Ayurveda Limited is trading at ₹244.75, with a market capitalisation of ₹521 Cr.
KRM Ayurveda Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
KRM Ayurveda Limited has a P/E of 25.9 and a return on equity of 17.54%.
KRM Ayurveda Limited is listed on the NSE under the symbol KRMAYURVED.
In Q1 FY27, KRM Ayurveda Limited reported revenue of ₹32 Cr and net profit of ₹9 Cr, with basic EPS of ₹4.27 (standalone, parsed from the company's exchange filing).
Promoters held 69.30% of KRM Ayurveda Limited's shares as of Sept 2026, against 69.15% in Mar 2026 (+0.15 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.